Nutritional aspects of breast cancer

Nutrition, in its broadest sense, plays a clear role in breast cancer, identified through its relationship to such known risk factors as rate of growth and development, age at menarche, adult height, postmenopausal body weight, and fat distribution. The relative importance of daily diet is hotly debated. There is no agreement on the relative importance of nutrition's effect, the responsible food groups and nutrients, nor the age or ages at which it can be influential. Evidence linking breast cancer and diet comes from human ecologic and observational studies as well as a body of experimental feeding studies in rats and mice. The population studies, including increasing numbers of migrant studies, and the animal experiments suggest that high-fat diets promote breast cancer, particularly among older women. Studies that compare diets of persons with and without breast cancer and those that record breast cancer incidence among women with different dietary histories have been inconclusive enough as to warrant randomized intervention trials. Recognition of differences between the risk factors for premenopausal and postmenopausal women and increasing insight into the ages at which known risk factors exert their influence have helped in the design of these trials. Human feeding studies and the trials themselves are identifying metabolic changes and their biomarkers as well as biomarkers for changes in fat and nutrient intakes. The Women's Health Initiative Dietary Modification Trial was designed to show whether a sustained (9-year) low-fat, high-fruit-and-vegetable eating pattern will lower the incidence of breast cancer among women who will be between ages 59 and 88 when the trial ends, the time of peak incidence. Meanwhile, the Women's Intervention Nutrition Study will learn in approximately 5 years whether a low-fat, adjuvant eating pattern will improve the prognoses of postmenopausal women with early and moderate stage breast cancer and whether tamoxifen should be used as at least part of their treatment. The results of these trials will have important applications for both public health and the provision of medical care.